{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:40:33Z","timestamp":1778586033765,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,5,23]]},"DOI":"10.3233\/jad-151136","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T12:00:35Z","timestamp":1464091235000},"page":"1111-1123","source":"Crossref","is-referenced-by-count":5,"title":["Immunization with Small Amyloid-\u03b2-derived Cyclopeptide Conjugates Diminishes Amyloid-\u03b2-Induced Neurodegeneration in Mice"],"prefix":"10.1177","volume":"52","author":[{"given":"Cornelis K.","family":"Mulder","sequence":"first","affiliation":[{"name":"University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Dong","sequence":"additional","affiliation":[{"name":"University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humphrey F.","family":"Brugghe","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans A.M.","family":"Timmermans","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichard","family":"Tilstra","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janny","family":"Westdijk","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly","family":"van Riet","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"van Steeg","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hoogerhout","sequence":"additional","affiliation":[{"name":"Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich L.M.","family":"Eisel","sequence":"additional","affiliation":[{"name":"University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-151136_ref1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151136_ref2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-151136_ref3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00005072-199655100-00001","article-title":"The pathogenesis of Alzheimer disease: An alternative to the amyloid hypothesis","volume":"55","author":"Terry","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-151136_ref4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","article-title":"Immunotherapeutic appro-aches for Alzheimer\u2019s disease","volume":"85","author":"Wisniewski","year":"2015","journal-title":"Neuron"},{"key":"10.3233\/JAD-151136_ref5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.neurobiolaging.2004.02.010","article-title":"Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer\u2019s disease","volume":"25","author":"Klein","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-151136_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-151136_ref7","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151136_ref8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4161\/pri.23061","article-title":"Prions, prionoids and pathogenic proteins in Alzheimer disease","volume":"7","author":"Ashe","year":"2013","journal-title":"Prion"},{"key":"10.3233\/JAD-151136_ref9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.3233\/JAD-151136_ref10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","article-title":"Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology","volume":"281","author":"Oddo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151136_ref11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.3233\/JAD-151136_ref12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jalz.2015.06.1884","article-title":"A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer\u2019s disease","volume":"11","author":"Agadjanyan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151136_ref13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurol.2014.10.003","article-title":"Amyloid beta peptide immunotherapy in Alzheimer disease","volume":"170","author":"Delrieu","year":"2014","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JAD-151136_ref14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4161\/hv.28183","article-title":"Vaccination against Alzheimer disease: An update on future strategies","volume":"10","author":"Fettelschoss","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.3233\/JAD-151136_ref15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-151136_ref16","first-page":"319","article-title":"Advances in the development of vaccines for Alzheimer\u2019s disease","volume":"15","author":"Lambracht-Washington","year":"2013","journal-title":"Discov Med"},{"key":"10.3233\/JAD-151136_ref17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-8-36","article-title":"Immunotherapy for Alzheimer\u2019s disease: Hoops and hurdles","volume":"8","author":"Lemere","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-151136_ref18","doi-asserted-by":"crossref","first-page":"0115237","DOI":"10.1371\/journal.pone.0115237","article-title":"Tailoring the antibody response to aggregated A\u03b2 using novel Alzheimer-vaccines.e","volume":"10","author":"Mandler","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-151136_ref19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCO.0000000000000041","article-title":"Is there still any hope for amyloid-based immunotherapy for Alzheimer\u2019s disease?","volume":"27","author":"Panza","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"10.3233\/JAD-151136_ref20","doi-asserted-by":"crossref","first-page":"e19110","DOI":"10.1371\/journal.pone.0019110","article-title":"A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid \u03b2 and elicits antibodies against oligomeric and fibrillar amyloid and plaques","volume":"6","author":"Hoogerhout","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-151136_ref21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuropharm.2010.07.013","article-title":"Calpain inhibition prevents amyloid-beta-induced neurodegeneration and associated behavioral dysfunction in rats","volume":"59","author":"Granic","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-151136_ref22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-2009-1052","article-title":"Pretreatment with lovastatin prevents N-methyl-D-aspartate-induced neurodegeneration in the magnocellular nucleus basalis and behavioral dysfunction","volume":"17","author":"Dolga","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151136_ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/1055-8330(95)90020-9","article-title":"Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+antagonist nimodipine, influence of aging and developmental drug treatment","volume":"4","author":"Luiten","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.3233\/JAD-151136_ref24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-3011.1994.tb00518.x","article-title":"Simultaneous multiple synthesis and selective conjugation of cyclized peptides derived from a surface loop of a meningococcal class 1 outer membrane protein","volume":"43","author":"Brugghe","year":"1994","journal-title":"Int J Pept Protein Res"},{"key":"10.3233\/JAD-151136_ref25","first-page":"229","volume-title":"Fmoc Solid Phase Peptide Synthesis: A Practical Approach","author":"Drijfhout","year":"2000"},{"key":"10.3233\/JAD-151136_ref26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/01971529708005819","article-title":"Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA","volume":"18","author":"Westdijk","year":"1997","journal-title":"J Immunoassay"},{"key":"10.3233\/JAD-151136_ref27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.3233\/JAD-151136_ref28","doi-asserted-by":"crossref","first-page":"32046","DOI":"10.1074\/jbc.M201750200","article-title":"Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability","volume":"277","author":"Dahlgren","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151136_ref29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-2010-1297","article-title":"LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity","volume":"19","author":"Granic","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151136_ref30","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1074\/jbc.M210207200","article-title":"In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis","volume":"278","author":"Stine","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151136_ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(00)00539-2","article-title":"Postnatal treatment with ACTH-(4-9) analog ORG 2766 attenuates N-methyl-D-aspartate-induced excitotoxicity in rat nucleus basalis in adulthood","volume":"405","author":"Horvath","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-151136_ref32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(01)00444-4","article-title":"Oral post-lesion administration of 5-HT(1A) receptor agonist repinotan hydrochloride (BAY x 3702) attenuates NMDA-induced delayed neuronal death in rat magnocellular nucleus basalis","volume":"108","author":"Harkany","year":"2001","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-151136_ref33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-4328(97)00091-0","article-title":"Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation","volume":"90","author":"Harkany","year":"1998","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-151136_ref34","volume-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"10.3233\/JAD-151136_ref35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00688184","article-title":"Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis","volume":"74","author":"Alafuzoff","year":"1987","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-151136_ref36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"key":"10.3233\/JAD-151136_ref37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-151136_ref38","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-151136_ref39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: Time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-151136_ref40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0022-510X(82)90155-1","article-title":"Plaques, tangles and dementia. A quantitative study","volume":"56","author":"Wilcock","year":"1982","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-151136_ref41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-151136_ref42","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-151136_ref43","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"10.3233\/JAD-151136_ref44","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain Abeta distinguish Alzheimer\u2019s disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-151136_ref45","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1074\/jbc.M110.191262","article-title":"Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro","volume":"286","author":"Moghekar","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151136_ref46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1620\/tjem.220.95","article-title":"Immunization therapy for Alzheimer disease: A comprehensive review of active immunization strategies","volume":"220","author":"Tabira","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.3233\/JAD-151136_ref47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-4159.2007.04499.x","article-title":"Effects of the monomeric, oligomeric, and fibrillar Abeta42 peptides on the proliferation and differentiation of adult neural stem cells from subventricular zone","volume":"102","author":"Heo","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-151136_ref48","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1523\/JNEUROSCI.13-04-01676.1993","article-title":"Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state","volume":"13","author":"Pike","year":"1993","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-151136_ref49","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.2928783","article-title":"Amyloid beta protein enhances the survival of hippocampal neurons in vitro","volume":"243","author":"Whitson","year":"1989","journal-title":"Science"},{"key":"10.3233\/JAD-151136_ref50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0304-3940(90)90867-9","article-title":"Beta-amyloid protein promotes neuritic branching in hippocampal cultures","volume":"110","author":"Whitson","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-151136_ref51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","article-title":"Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuroeptides","volume":"250","author":"Yankner","year":"1990","journal-title":"Science"},{"key":"10.3233\/JAD-151136_ref52","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1073\/pnas.1215165110","article-title":"Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer\u2019s disease-related pathology","volume":"110","author":"Michaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-151136_ref53","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1517\/14712598.2013.838556","article-title":"Monophosphoryl lipid A is an lipopolys-accharide-derived Toll-like receptor 4 agonist which may improve Alzheimer\u2019s disease pathology","volume":"13","author":"Wang","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.3233\/JAD-151136_ref54","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1007\/s11064-008-9715-8","article-title":"Intra-peritoneal injection of polyclonal anti-interferon alpha antibodies cross the blood brain barrier and neutralize interferon alpha","volume":"33","author":"Sas","year":"2008","journal-title":"Neurochem Res"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-151136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:46Z","timestamp":1777370566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-151136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":54,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-151136","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}